Results 1 to 10 of about 12,104,587 (437)

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

open access: yesHepatology, 2023
The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language.
M. Rinella   +52 more
semanticscholar   +1 more source

Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2022
Objectives. We assessed the potential of glial cell line-derived neurotrophic factor (GDNF) as a useful biomarker to predict cirrhosis in chronic hepatitis B (CHB) patients. Methods.
Guangyue Yang   +17 more
doaj   +1 more source

Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt/β-Catenin Pathway

open access: yesAnalytical Cellular Pathology, 2022
Nowadays, microRNA-375 (miR-375) has been implicated in many types of cancers, including hepatocellular carcinoma (HCC), and the functions of miRNAs encapsulated by extracellular vesicles (EV) in HCC progression have also been extensively investigated ...
Zhaoxia Yu   +5 more
doaj   +1 more source

Sphingomyelinases and Liver Diseases [PDF]

open access: yesBiomolecules, 2020
Sphingolipids (SLs) are critical components of membrane bilayers that play a crucial role in their physico-chemical properties. Ceramide is the prototype and most studied SL due to its role as a second messenger in the regulation of multiple signaling pathways and cellular processes.
Naroa Insausti-Urkia   +3 more
openaire   +4 more sources

Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma

open access: yesBMC Gastroenterology, 2023
Background  Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and is characterized by insidious onset, rapid progression, and poor prognosis. Immunotherapy is a first-line treatment for advanced HCC.
Rui Hu   +13 more
doaj   +1 more source

Characterization of Frequency-Dependent Material Properties of Human Liver and its Pathologies Using an Impact Hammer [PDF]

open access: yesMedical Image Analysis, 2011, Vol. 15, No.1, pp. 45-52, 2021
The current methods for characterization of frequency-dependent material properties of human liver are very limited. In fact, there is almost no data available in the literature showing the variation in dynamic elastic modulus of healthy or diseased human liver as a function of excitation frequency.
arxiv   +1 more source

Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma

open access: yesEmergency Medicine International, 2022
Objectives. To investigate the effects of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) on liver function and immune function in patients with hepatocellular carcinoma (HCC). Methods.
Yan Zhou   +6 more
doaj   +1 more source

FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma

open access: yesScientific Reports, 2023
Peripheral blood mononuclear cell (PBMC) genes reflect the host immune status and could be suitable for evaluating the prognosis of patients with hepatocellular carcinoma (HCC), for which a reliable biomarker is unavailable and the host immune responses ...
Jing Li   +10 more
doaj   +1 more source

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.

open access: yesGastroenterology, 2020
Fatty liver associated with metabolic dysfunction is common, affects a quarter of the population, and has no approved drug therapy. While pharmacotherapies are in development, response rates appear modest.
M. Eslam, A. Sanyal, J. George
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy